Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Sienna Biopharmaceuticals, Inc. (SNNAQ) had Cash Flow from Investing Activities of $-0.00M for the most recently reported fiscal quarter, ending 2019-09-30.
| Income Statement Financials | |
-- |
|
$-3.97M |
|
-- |
|
-- |
|
$6.04M |
|
$-6.04M |
|
$-2.55M |
|
$-8.59M |
|
$-8.59M |
|
$-3.97M |
|
$-3.97M |
|
$-3.97M |
|
$-3.97M |
|
$-6.04M |
|
$4.86M |
|
30.73M |
|
30.73M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$19.73M |
|
$0.18M |
|
$23.76M |
|
$43.49M |
|
$1.29M |
|
-- |
|
$19.10M |
|
$20.39M |
|
$23.10M |
|
$23.10M |
|
$23.10M |
|
30.77M |
|
| Cash Flow Statement Financials | |
$-39.03M |
|
|
Cash Flow from Investing Activities |
$-0.00M |
$1.88M |
|
$48.71M |
|
$11.54M |
|
$-37.16M |
|
$3.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.19% |
|
-17.19% |
|
-9.13% |
|
-17.19% |
|
$0.75 |
|
$-1.27 |
|
$-1.27 |
|